When AI Stops Taking Notes and Starts Seeing Patients
Summary
- Over 80% of US physicians now use AI in their workflow, with Doctronic facilitating nearly 30 million AI medical interactions.
- The healthcare market is an aggregate of hundreds of separate businesses totaling $5 trillion, anchored by the patient as the atomic unit of value.
- AI adoption initially focused on the administrative right side of the patient journey, addressing $1.2 trillion in administrative spend, but is now shifting left toward high-stakes clinical work.
- Abridge, a Lightspeed portfolio company, is expanding from scribing to a patient-centered clinician intelligence platform to drive upstream value.
- Doctronic operates as an autonomous front door, being the first US company cleared to renew certain chronic prescriptions without a physician in the loop.
- In Doctronic's Utah pilot, over 97% of autonomous prescription renewal decisions matched human physician outcomes.
- Doctronic's growth includes direct-to-consumer revenue increasing 20x since its Series A, nearly 30 million AI consults, and the top Google ranking for "AI doctor."
- Neko represents a proactive front door by using proprietary hardware to scan patients for baseline health data, enabling personalized preventive care.
- Neko has generated millions of data points per scan across eight live clinics, with a New York location opening soon and over 100,000 people on a waitlist.
- Both Doctronic & Neko target the patient as the primary buyer to build trust, data loops, & regulatory advantages before downstream expansion.
- The investment thesis relies on increasing regulatory clearance for autonomous tasks, sustained accuracy, & the ability to convert trust into clearance.
- The future frontier for clinical AI is predicted to move from consultative tasks to procedural & eventually surgical applications requiring physical intervention.
The most valuable position in healthcare AI, we’d argue, belongs to whoever becomes the front door.